Christopher Darr
Impact in
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Renal cell carcinoma treatment
- Urology top 10%
Papers in ⓘ
-
- Prostate Cancer Treatment and Research 14
- Renal cell carcinoma treatment 11
- Prostate Cancer Diagnosis and Treatment 11
- Surgery 21
- Bladder and Urothelial Cancer Treatments 15
- Urinary and Genital Oncology Studies 8
- Co-authors
- Boris Hadaschik (40 shared papers)Ken Herrmann (12 shared papers)Jan Philipp Radtke (15 shared papers)Claudia Kesch (18 shared papers)Stephan Tschirdewahn (16 shared papers)Ulrich Krafft (20 shared papers)Viktor Grünwald (24 shared papers)Henning Reis (17 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)Journal of Nuclear Medicine (4 papers)Cancers (3 papers)Theranostics (2 papers)Annals of Oncology (2 papers)
- Partner nations
- GermanyHungarySwitzerland
In The Last Decade
Christopher Darr
49 papers receiving 497 citations
Hit Papers
Peers
Comparison fields: 5 of 70
- Pulmonary and Respiratory Medicine 272
- Urology 31
- Oncology 131
- Radiology, Nuclear Medicine and Imaging 110
- Rheumatology 61
Countries citing papers authored by Christopher Darr
This map shows the geographic impact of Christopher Darr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Darr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Darr more than expected).
Fields of papers citing papers by Christopher Darr
This network shows the impact of papers produced by Christopher Darr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Darr. The network helps show where Christopher Darr may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Darr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Metastatic Prostate Cancer—A Review of Current Treatment Options and Promising New Approaches Hit paper breakdown → | 2023 | 80 |
| 2 | 2021 | 58 | |
| 3 | 2020 | 49 | |
| 4 | 2020 | 33 | |
| 5 | 2020 | 31 | |
| 6 | 2017 | 31 | |
| 7 | 2021 | 24 | |
| 8 | 2014 | 15 | |
| 9 | 2023 | 15 | |
| 10 | 2022 | 13 | |
| 11 | 2020 | 12 | |
| 12 | 2015 | 10 | |
| 13 | 2018 | 10 | |
| 14 | 2021 | 9 | |
| 15 | 2020 | 8 | |
| 16 | 2019 | 8 | |
| 17 | 2021 | 7 | |
| 18 | 2021 | 7 | |
| 19 | 2021 | 6 | |
| 20 | 2022 | 6 |
About Christopher Darr
Christopher Darr is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 58 papers that have together received 501 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (15 papers), Prostate Cancer Treatment and Research (14 papers), Renal cell carcinoma treatment (11 papers), Prostate Cancer Diagnosis and Treatment (11 papers), Urinary and Genital Oncology Studies (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (272 citations), Urology (31 citations), Oncology (131 citations), Radiology, Nuclear Medicine and Imaging (110 citations) and Rheumatology (61 citations). Christopher Darr has collaborated with scholars based in Germany, Hungary and Switzerland. Frequent co-authors include Boris Hadaschik, Ken Herrmann, Jan Philipp Radtke, Claudia Kesch, Stephan Tschirdewahn, Ulrich Krafft, Viktor Grünwald, Henning Reis, Tibor Szarvas and Gerhard Weinreich. Their work appears in journals such as Journal of Clinical Oncology, Journal of Nuclear Medicine, Cancers, Theranostics and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.